Increased PAD2 abundance in late-onset FGR placentas is consistent with the broad tissue distribution of this isozyme and its reported upregulation in other diseases, including several neurodegenerative conditions and cancers [64,65,66]. The gene discussed is PADI2; the disease is cancer.